Ornithine Transcarbamylase Deficiency Treatment Market Future Growth and Demand and COVID19 Impact Analysis Covered
“Conferment of orphan drug status by regulatory bodies is motivating manufacturers to accelerate development of novel OTC deficiency treatment formulations,” infers a Fact.MR analyst.
View full press release